REVIEW ON DIABETES MELLITUS

PRATIBHA R.VANNARWAD; AKSHATA B. LASURE; NANDKISHOR B.BAVAGE; SHYAMLILA B.BAVAGE

REVIEW ON DIABETES MELLITUS

Authors: PRATIBHA R.VANNARWAD, AKSHATA B. LASURE, NANDKISHOR B.BAVAGE, SHYAMLILA B.BAVAGE

Unique Paper ID: 153243
Volume: 8
Issue: 6
PageNo: 213-218

Keywords: Diabetes mellitus type 1diabetes mellitus type 2 diabetes mellitus gastational diabetes mellitus insulin.

Abstract:
Diabetes mellitus may be a cluster of metabolic diseases characterized by hyperglycemia ensuing from defects in hypoglycemic agent secretion, hypoglycemic agent action, or both. The chronic hyperglycemia of diabetes is associated with semi-permanent harm, dysfunction, and failure of varied organs, especially the eyes, kidneys, nerves, heart, and blood vessels. Several unhealthful processes square measure concern with in the development of diabetes. These vary from autoimmune destruction of the beta-cells of the exocrine gland with ensuant insulin deficiency to abnormalities that lead to resistance to insulin action.. In the latter, class a degree of hyperglycemia enough to cause pathologic and purposeful changes in varied target tissues, However while not clinical symptoms, may be present for a long period of time before polygenic disease is recognize. Throughout this asymptomatic period, it is doable to demonstrate an abnormality in macromolecules metabolism by measure of plasma aldohexone in the fasting state or after a challenge with an oral aldohexone load.The degree of hyperglycemia (if any) could amendment over time, looking on the extent of the basic disease process . A illness method could also be gift however might not have progressed far enough to cause hyperglycemia. The same disease process can cause impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) while not fulfilling the standards for the diagnosis of polygenic disease . In some specific with diabetes, adequate glycemic control can be achieved with weight reduction, exercise, and/or oral aldohexone lowering agents. These individuals therefore do not require insulin. Other individuals who have some residual hypoglycemic agent secretion but require exogenous insulin for adequate glycemic control can survive without it. Individuals with extensive beta-cell destruction and therefore no residual insulin secretion need hypoglycemic agent for survival. The seriousness of the metabolic abnormality will progress, regress, or keep an equivalent. Thus, the degree of hyperglycemia reflects the severity of the underlying biological process and its treatment quite the character of the strategy itself.

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 8
Issue: 6
PageNo: 213-218

REVIEW ON DIABETES MELLITUS

Available:https://ijirt.org/Article?manuscript=153243

17 Oct, 2021

DRUG REPURPOSING IN ANTIVIRAL RESEARCH: A REVIEW

08 Aug, 2021

RHINO-ORBITAL MUCORMYCOSIS ASSOCIATED WITH COVID-19

08 Aug, 2021

THE PRINCIPLES OF SKIN TISSUE ENGINEERING

08 Aug, 2021

A REVIEW ON LYME BORRELIOSIS

31 Jul, 2021

AWARENESS ABOUT BANNED DRUG

31 Jul, 2021

APPLICATION AND THE PRODUCTION OF RADIOPHARMACEUTICAL’S

30 Jul, 2021

ANTHELMINTIC ACTIVITY OF SOME MEDICINAL PLANTS

30 Jul, 2021

A REVIEW ON DRUMSTICK PLANTS (MORINGA OLEIFERA) MEDICAL USES AND NUTRITIONAL PROPERTIES

29 Jul, 2021

PHARMACOTHERAY OF HYPERTENSION

29 Jul, 2021

DIAGNOSTIC AND THERAPEUTIC STRATEGIES FOR COVID-19

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry